Gholson Lyon is a psychiatrist and physician-scientist at Cold Spring Harbor Laboratory (CSHL). He earned an M.Phil. in Genetics at the University of Cambridge, England, then received a Ph.D. and M.D. through the combined Cornell/Sloan-Kettering/Rockefeller University training program. He completed clinical residencies in child, adolescent and adult psychiatry at Columbia and NYU-Bellevue, and he started his independent research career at the University of Utah in 2009. Dr. Lyon joined Cold Spring Harbor Laboratory in 2012, where he studies the molecular basis of a new rare disease, involving the amino-terminal acetylation of proteins, which he and his colleagues discovered in Utah. They have named this rare disease Ogden Syndrome in honor of the town in which the family lives. Dr. Lyon also works within the Stanley Institute for Cognitive Genomics at CSHL to investigate the pathophysiological basis of neuropsychiatric conditions, with a long-term goal of expanding access to preventive services and treatment for these disorders. Dr. Lyon is also committed to the open discussion and management of the ethical implications of human genetics research, along with helping to move whole genome sequencing into the clinical world.